HRT Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.4M | Buy |
+35,618
| New | +$5.4M | 0.02% | 397 |
|
|
2024
Q4 | – | Sell |
-14,769
| Closed | -$2.91M | – | 2322 |
|
|
2024
Q3 | $2.91M | Buy |
+14,769
| New | +$2.91M | 0.01% | 668 |
|
|
2024
Q2 | – | Sell |
-4,856
| Closed | -$1.32M | – | 2172 |
|
|
2024
Q1 | $1.32M | Buy |
+4,856
| New | +$1.32M | 0.01% | 726 |
|
|
2023
Q3 | – | Sell |
-22,835
| Closed | -$4.8M | – | 2264 |
|
|
2023
Q2 | $4.8M | Buy |
22,835
+6,002
| +36% | +$1.26M | 0.04% | 287 |
|
|
2023
Q1 | $3.4M | Buy |
+16,833
| New | +$3.4M | 0.04% | 360 |
|
|
2022
Q3 | – | Sell |
-9,891
| Closed | -$2.12M | – | 2715 |
|
|
2022
Q2 | $2.12M | Buy |
+9,891
| New | +$2.12M | 0.02% | 536 |
|
|
2021
Q2 | – | Sell |
-58,879
| Closed | -$17.1M | – | 2838 |
|
|
2021
Q1 | $17.1M | Buy |
58,879
+1,990
| +3% | +$577K | 0.17% | 63 |
|
|
2020
Q4 | $14.2M | Buy |
56,889
+18,401
| +48% | +$4.6M | 0.29% | 56 |
|
|
2020
Q3 | $8.72M | Buy |
+38,488
| New | +$8.72M | 0.25% | 59 |
|
|
2019
Q4 | – | Sell |
-7,104
| Closed | -$940K | – | 1167 |
|
|
2019
Q3 | $940K | Buy |
+7,104
| New | +$940K | 0.04% | 317 |
|